Slowly expanding/evolving lesions as a magnetic resonance imaging marker of chronic active multiple sclerosis lesions.

BACKGROUND:Chronic lesion activity driven by smoldering inflammation is a pathological hallmark of progressive forms of multiple sclerosis (MS). OBJECTIVE:To develop a method for automatic detection of slowly expanding/evolving lesions (SELs) on conventional brain magnetic resonance imaging (MRI) and characterize such SELs in primary progressive MS (PPMS) and relapsing MS (RMS) populations. METHODS:We defined SELs as contiguous regions of existing T2 lesions showing local expansion assessed by the Jacobian determinant of the deformation between reference and follow-up scans. SEL candidates were assigned a heuristic score based on concentricity and constancy of change in T2- and T1-weighted MRIs. SELs were examined in 1334 RMS patients and 555 PPMS patients. RESULTS:Compared with RMS patients, PPMS patients had higher numbers of SELs (p = 0.002) and higher T2 volumes of SELs (p < 0.001). SELs were devoid of gadolinium enhancement. Compared with areas of T2 lesions not classified as SEL, SELs had significantly lower T1 intensity at baseline and larger decrease in T1 intensity over time. CONCLUSION:We suggest that SELs reflect chronic tissue loss in the absence of ongoing acute inflammation. SELs may represent a conventional brain MRI correlate of chronic active MS lesions and a candidate biomarker for smoldering inflammation in MS

Atrophy in multiple sclerosis: Measurement and clinical implications

This thesis describes the development and application of new magnetic resonance imaging techniques to characterise and quantify underlying tissue changes in multiple sclerosis (MS) that are responsible for or associated with disability. Characterisation, measurement of such changes and their relationship to other quantitative parameters of disease activity or progression may yield important information on the pathophysiology of disability in MS. They would also be of considerable value in evaluating a putative treatment. The work described focuses on the measurement of spinal cord and cerebral atrophy. The development and evaluation of new highly reproducible quantitative techniques are described. The results of cross-sectional and longitudinal clinical studies presented. These demonstrate that the measurement of atrophy is a powerful way in which to monitor clinically relevant disease progression. The results also indicate that the development of atrophy in MS is common. The techniques are reviewed critically, compared to other current clinical and imaging measures of disease progression and shown to have high sensitivity to change and greater possible specificity to underlying pathology. The role of axonal loss in the development of atrophy and it's relationship to inflammatory activity are discussed. It is concluded that atrophy may develop independently of inflammation. Finally improved techniques to further investigate the nature and significance of atrophy are suggested

Clinical and MRI features of primary progressive multiple sclerosis.

In approximately 10-15% of cases Multiple Sclerosis follows a progressive rather than a relapsing course and this is known as Primary Progressive Multiple Sclerosis (PPMS). In this thesis previous clinical, pathological and Magnetic Resonance Imaging (MRI) studies of PPMS are reviewed and new studies using two cohorts of patients with PPMS are presented. In the first of these studies an existing cohort of patients with PPMS are re-examined at first two, and then five years, clinically and with MRI, to provide the longest period of MRI follow up in the condition to date. Changes in clinical and MRI measures over this time, and their correlation, are described. Over this extended period, some limited correlation can be found between clinical and MRI measures in PPMS. It is also seen that there is great variability in the rate of MRI and clinical progression between individuals with PPMS, although for a given individual progression is relatively constant. The possible implications of this observation for the nature of the underlying disease process are discussed. The second part of this thesis describes the clinical and MRI features of a second cohort of patients with clinically early PPMS, examined within five years of the first onset of symptoms, the first study to examine this stage of the condition. It is seen that much of the MRI variation seen in established PPMS is already present at this time and that the degree of MRI abnormality, even at this early stage, can be substantial. The specific question as to whether a distinct, early, inflammatory phase occurs in the condition (on the model of the more fully studied relapsing MS subtype) is addressed by the use of triple dose Gadolinium in a subgroup of this cohort examined over six months and evidence for the possible existence of such a phase in some patients with PPMS is found

Understanding progression in primary progressive multiple sclerosis: a longitudinal clinical and magnetic resonance imaging study

The work in this thesis applies magnetization transfer imaging (MTI) and conventional MRI measures (brain volume, T2 lesion load and enhancing lesions) to investigate the mechanisms underlying progression in primary progressive multiple sclerosis (PPMS), and identifies MR markers to predict and monitor progression. First, we demonstrated that MTI was sensitive to change in the normal appearing brain tissues over one year, and that clinical progression over this period was predicted by baseline normal appearing white matter (NAWM) MT ratio (MTR). However, our second study showed that over three years, grey matter MTR became a better predictor of progression than any other MRI measure. Grey matter MTR and T2 lesion load changes reflected concurrent progression during this study. To localize the baseline grey matter injury more precisely, we developed a voxelbased technique to identify areas of grey matter MTR reduction and volume loss in patients compared with controls. The regions of grey matter MTR reduction identified correlated with clinical function in anatomically related systems. Finally, because our studies showed that lesion load influenced progression, we used contrast enhanced T1-weighted imaging to examine active focal inflammation. We found that while lesion activity declined over five years, levels of activity at the start of the study could influence mobility five years later. The work presented in this thesis suggests that grey matter damage has a predilection for certain brain regions and is an important determinant of progression in early PPMS. In the white matter, changes in lesion volume and activity continue to influence progression, but NAWM injury may have a declining role. MTR is a sensitive and responsive tool for predicting, monitoring, and localizing clinically relevant brain injury in early PPMS

Diffusion Tensor Imaging in a Large Longitudinal Series of Patients With Cervical Spondylotic Myelopathy Correlated With Long-Term Functional Outcome

BACKGROUND Fractional anisotropy (FA) of the high cervical cord correlates with upper limb function in acute cervical cord injury. We investigated the correlation between preoperative FA at the level of maximal compression and functional recovery in a group of patients after decompressive surgery for cervical spondylotic myelopathy (CSM). OBJECTIVE To determine the usefulness of FA as a biomarker for severity of CSM and as a prognostic biomarker for improvement after surgery. METHODS Patients received diffusion tensor imaging (DTI) scans preoperatively. FA values of the whole cord cross-section at the level of maximal compression and upper cervical cord (C1-2) were calculated. Functional status was measured using the modified Japanese Orthopedic Association (mJOA) scale preoperatively and at follow-up up to 2 yr. Regression analysis between FA and mJOA was performed. DTI at C4-7 was obtained in controls. RESULTS Forty-four CSM patients enrolled prior to decompression were compared with 24 controls. FA at the level of maximal compression correlated positively with preoperative mJOA score. Preoperative FA correlated inversely with recovery throughout the postoperative period. This was statistically significant at 12 mo postoperation and nearly so at 6 and 24 mo. Patients with preoperative FA0.55. CONCLUSION In the largest longitudinal study of this kind, FA promises a valid biomarker for severity of CSM and postoperative improvement. FA is an objective measure of function and could provide a basis for prognosis. FA is particularly useful if preoperative values are less than 0.55

The prognostic value of white-matter selective double inversion recovery mri sequence in multiple sclerosis: an exploratory study

Using a white-matter selective double inversion recovery sequence (WM-DIR) that suppresses both grey matter (GM) and cerebrospinal fluid (CSF) signals, some white matter (WM) lesions appear surrounded by a dark rim. These dark rim lesions (DRLs) seem to be specific for multiple sclerosis (MS). They could be of great usefulness in clinical practice, proving to increase the MRI diagnostic criteria specificity. The aims of this study are the identification of DRLs on 1.5 T MRI, the exploration of the relationship between DRLs and disease course, the characterization of DRLs with respect to perilesional normal-appearing WM using magnetization transfer imaging, and the investigation of possible differences in the underlying tissue properties by assessing WM-DIR images obtained at 3.0 T MRI. DRLs are frequent in primary progressive MS (PPMS) patients. Amongst relapsing-remitting MS (RRMS) patients, DRLs are associated with a high risk of the disease worsening and secondary progressive MS (SPMS) conversion after 15 years. The mean magnetization transfer ratio (MTR) of DRLs is significantly different from the lesion without the dark rim, suggesting that DRLs correspond to more destructive lesions

MRI evaluation of the anti-adhesion molecule antibody Natalizumab and the blood-brain barrier in Multiple Sclerosis

As Blood-brain barrier (BBB) breakdown is central to inflammatory lesion formation, it presents a potential target in the formulation of putative therapeutic agents in MS. The action of natalizumab, a monoclonal antibody acting at the BBB, is investigated through a phase III monotherapy trial (AFFIRM) and associated substudies. Subtle BBB disruption from non-inflamed lesions, which could contribute to axonal damage through leakage of inflammatory cells and associated mediators into surrounding parenchyma, is also studied. Introductory chapters (1-3) provide a brief overview of MS, clinical trials, magnetic resonance imaging (MRI), the BBB and natalizumab. Chapter four describes MRI results of AFFIRM- a 2 year multi-centre trial involving 942 patients. Compared with placebo, natalizumab reduced number of gadolinium (Gd)- enhancing lesions by 92%, new/enlarging T2-hyperintense lesions by 83%, and new T1- hypointense lesions by 76%. Chapter five describes a 57 patient AFFIRM trial substudy in which the influence of natalizumab on segmental atrophy was investigated. Atrophy was predominant in grey matter (GM) and was independent of lesion load. Fluctuations in white matter (WM) volume followed changes in inflammatory lesion load. Atrophy was not influenced by natalizumab. The effect of natalizumab on subtle BBB disruption (inferred by measuring the post-Gd %change in T1 weighted signal intensity) is studied in chapter 6. This AFFIRM substudy involved 40 patients (27 on natalizumab, 13 on placebo.) Although subtle BBB leakage was consistently detected in non-visibly enhancing lesions, natalizumab did not influence the degree of leakage. Chapter 7 describes a cross-sectional study which utilised post-Gd change in R1 (1/T1) as a marker BBB leakage. 19 patients (10 RRMS, 9 SPMS) were involved in this study. The subtle leakage observed from non-visibly enhancing lesions was distinct from leakage from visibly enhancing lesions. This was sustained over 60 minutes, greater in smaller lesions and in size-adjusted T1 hypointense lesions

Development of an image processing pipeline for the study of corticol lesions in multiple sclerosis patients using ultra-high field MRI

Tese de mestrado integrado, Engenharia Biomédica e Biofísica (Biofísica Médica e Fisiologia de Sistemas), Universidade de Lisboa, Faculdade de Ciências, 2019A esclerose múltipla é uma doença crónica e inflamatória do sistema nervoso central de alta prevalência nos dias de hoje. Durante anos, o foco da doença foi a patologia visível na matéria branca. Apesar dos primeiros estudos de patologia cortical em esclerose múltipla apontarem para a década de 60, foi apenas no início do novo século que o córtex passou a ser estudado como parte integral da doença. Desde então, estudos têm vindo a demonstrar que o comprometimento do córtex parece estar relacionado com danos cognitivos e físicos, frequentemente associados à doença. A necessidade de melhor compreender o impacto das lesões corticais no desenvolvimento da doença e na vida diária destes pacientes tem motivado o seu estudo, sendo a Ressonância Magnética (RM), em particular scanners de campo ultra-alto, a melhor ferramenta para as detetar e estudar. A melhoria da razão sinal-ruído e da resolução espacial dos scanners de RM de campo ultra-alto tem permitido o aumento da deteção de lesões corticais. Ainda assim, a sua sensibilidade continua a não ser ideal e a estar fortemente dependente do tipo de lesão cortical, do contraste de RM usado na sua deteção e da existência de ferramentas robustas que permitam a sua deteção de modo automático, mais eficiente e com menor espaço para erro. A falta de marcadores de imagem para a remielinização ou desmielinização parcial, tal como a ausência de diretrizes para a deteção destas lesões com campos de 7 (T)esla parece explicar a dificuldade em distinguir e identificar falsos positivos e as diferenças encontradas nas deteções realizadas por diferentes avaliadores. Uma desvantagem dos scanners de campo ultra-alto é o maior efeito de bias que, caso não seja removido aquando da aquisição de imagens, terá de ser removido na fase de processamento por softwares e algoritmos que não estão originalmente construídos para trabalhar com imagens de maior resolução e cuja prestação não está ainda bem explorada nestas condições. Estes desafios comprometem o potencial dos scanners de RM de campo ultra-alto para o estudo das lesões corticais na esclerose múltipla. Este projeto procura desenvolver uma pipeline semiautomática para o pré-processamento e processamento de imagens de RM de cariz estrutural de doentes com esclerose múltipla obtidas num scanner de campo ultra-alto. A pipeline é criada de modo gradual, recorrendo a análises visuais, ou de outro tipo, para confirmar a qualidade de cada passo antes de avançar para o seguinte, no pressuposto de que a qualidade dos softwares de imagem comercialmente disponíveis será menor ao utilizar imagens de maior resolução. A ocorrência de lesões corticais no córtex sensório-motor (SM1) é igualmente determinada e usada para validar a qualidade da pipeline. Doze doentes com esclerose múltipla na sua forma recidivante-remitente ou secundariamente progressiva e seis controlos foram incluídos neste projeto. Todas as permissões necessárias do comité local de ética, proteção de dados e da Danish Medicines Agency foram previamente obtidas. Os doentes foram estudados num scanner de RM de corpo inteiro da Philips, Achieva 7,0 T, dedicado a investigação. Os participantes foram observados usando quatro tipos distintos de contraste: magnetization prepared rapid acquisition by gradient echo (MPRAGE) a três dimensões (3D) com 0,65-mm de resolução isotrópica, 3D fluid attenuated inversion recovery (FLAIR) com 0,7-mm de resolução isotrópica, 3D T1-weighted (T1w) de resolução 0,85x0,85x1,0 mm3 e 3D T2-weighted Turbo Spin Echo (T2w-TSE) de 0,4-mm de resolução isotrópica. A vertente de pré-processamento da pipeline incluiu uma correção de bias e o co-registo de imagens. Para a correção de bias, o software SPM foi testado utilizando os parâmetros habituais e uma alteração dos parâmetros relativos à smoothness e regularização, como sugerido na literatura. O processo de co-registo seguiu o procedimento utilizado no processamento de imagens de doentes com esclerose múltipla de 3 T no Danish Research Centre for Magnetic Resonance (DRCMR), com alterações posteriormente adicionadas para melhorar a qualidade do alinhamento das imagens de cada indivíduo a 7 T. Após o pré-processamento, uma deteção de lesões corticais, seguida da sua segmentação, foi realizada manualmente utilizando as ferramentas do software FSL. A vertente de processamento da pipeline incluiu uma segmentação do cérebro, um registo das imagens dos doentes e a criação de superfícies corticais. A segmentação foi testada utilizando três diferentes ferramentas: o software SPM, uma toolbox do SPM, CAT, e a ferramenta de segmentação do FSL, FAST. A toolbox do SPM, DARTEL, foi usada no registo de imagens e o software FreeSurfer permitiu a criação de superfícies individuais e de grupo no último passo da pipeline. As máscaras com as lesões criadas após a segmentação manual de lesões seguiram um caminho semelhante de processamento de modo a permitir a sua correta sobreposição no respetivo volume, e, posteriormente, superfície, e a possibilidade de fazer análises individuais ou de grupo. Os resultados obtidos mostraram que os softwares para processamento de imagens de RM disponíveis apresentam, em geral, uma boa prestação e fornecem resultados de confiança. Ainda assim, a sua prestação pode ser otimizada incluindo procedimentos adicionais em cada passo ou por alteração das configurações originais dos softwares. A diminuição do parâmetro de largura à meia altura com um aumento do parâmetro de regularização na correção de bias com o SPM permitiu a criação de campos de bias mais fieis às imagens originais, consequentemente melhorando a sua correção e a diferenciação da matéria branca e matéria cinzenta nas imagens resultantes. A criação adicional de máscaras contendo apenas o cérebro e a utilização exclusiva de transformações de corpo rígido no co-registo de imagens permitiu a utilização de vários contrastes na tarefa de deteção de lesões, sem interferir com a sua localização ou morfologia. Na segmentação, a toolbox do SPM, CAT, mostrou melhorias na capacidade de separar as diferentes classes de tecidos com maior confiança e qualidade, particularmente nas regiões de contacto entre a matéria branca e cinzenta. Consequentemente, a qualidade do alinhamento das imagens dos diferentes doentes e a posterior criação de uma imagem média a partir de imagens individuais foi melhorada. O sucesso da pipeline permitiu a sobreposição das lesões corticais manualmente segmentadas nas superfícies individuais e/ou comuns criadas, onde foi descoberto que a maioria das lesões ocorreu no hemisfério direito, com sobreposições de lesões respetivas a diferentes doentes a ocorrer maioritariamente nos sulcos corticais, comparativamente aos giros. Porém, a segmentação de lesões demonstrou ser dispendiosa, dependente do avaliador e altamente influenciada por fatores inerentes ao avaliador, tal como o cansaço, nível de concentração ou de aborrecimento, e fatores externos, no qual se destacam a luminosidade do computador ou a luminosidade da sala onde a deteção foi feita. A feature do FreeSurfer para imagens de maior resolução não se mostrou fiável no tratamento dos dados de resolução isotrópica de 0,5-mm deste projeto, uma possível razão pela qual ainda se encontra em desenvolvimento. Apesar dos bons resultados obtidos, investigação adicional será necessária para melhor compreender a prestação destes e de outros softwares para imagem médica no processamento de imagens de RM de maior resolução, tal como a melhor maneira de tirar partido dos mesmos em estudos clínicos a 7 T. A extensão da pipeline a outros doentes com esclerose múltipla irá aumentar a amostra em estudo e permitir um estudo mais extensivo da patologia cortical e a compreensão do impacto de uma ou mais lesões localizadas na região SM1 na conectividade e integridade funcional da região cortical afetada.The importance of grey matter pathology to the understanding of multiple sclerosis has been acknowledged. However, the sensitivity to cortical lesions is limited when using conventional magnetic resonance imaging (MRI) systems. Ultra-high field (UHF) MRI systems have improved detection sensitivity but impose the additional challenge of a higher effect of bias to account for. Currently, image processing tools are not designed for higher resolution data and the performance of common software packages under these conditions has not been properly explored. These challenges have impaired the potential of UHF-MRI to study cortical lesions in multiple sclerosis. This project aims at developing a semi-automated pipeline for the pre-processing and processing of structural UHF-MRI data of multiple sclerosis patients. The pipeline is built in a step-by-step fashion, making use of visual assessments and other analyses to confirm the quality of each step before advancing to the next, under the assumption that the performance of common imaging software packages will be poorer when using higher resolution data. The occurrence of cortical lesions within the primary sensory-motor cortex (SM1) is also determined and used to validate the quality of the pipeline. Twelve patients with relapsing-remitting multiple sclerosis or secondary progressive multiple sclerosis and six healthy age-matched controls were included in this project. All relevant permissions from the local ethics committee and data protection had been obtained beforehand. All participants were studied with whole-brain ultra-high field MRI at 7 Tesla (T), using a research-only 7 T Achieva MR system. The participants were scanned using four different MRI modalities, namely 3-dimensional (3D) magnetization prepared rapid acquisition by gradient echo (MPRAGE) at 0.65-mm isotropic resolution, 3D fluid attenuated inversion recovery (FLAIR) at 0.7-mm isotropic resolution, 3D T1-weighted (T1w) of 0.85x0.85x1.0 mm3 reconstructed resolution and 3D T2-weighted Turbo Spin Echo (T2w-TSE) at 0.4-mm isotropic reconstructed resolution. The pre-processing pipeline included a bias correction and a coregistration step. For the bias correction, SPM was tested using its default parameters and an alternative configuration that altered the smoothness and regularization parameters. The coregistration followed an approach used in the processing of multiple sclerosis data at 3 T, with changes added to improve the quality of the within-subject alignment at 7 T. After the data pre-processing, manual detection and segmentation of cortical lesions was performed using FSLeyes. The processing pipeline included brain segmentation, subject registration and cortical surface creation. Brain segmentation was tested with SPM, with SPM’s toolbox, CAT, and with FSL’s segmentation tool, FAST. SPM’s DARTEL tool was used for subject registration and FreeSurfer allowed the creation of individual and an average cortical surface. The lesion masks created after the manual segmentation task followed a similar processing route to allow their overlay on the respective brain volumes and, posteriorly, surfaces, and the possibility of individual and group analyses. Results showed that the currently available MRI image processing tools present overall good performance and reliability in the processing of higher resolution data of multiple sclerosis patients. Still, the quality of the outcomes can be optimized by including additional steps or changes to the original software configurations. Modifying SPM’s smoothness and regularization parameters for the estimation of bias minimized its effect in the data, allowing a better differentiation between grey matter and white matter. Removing the skull whilst keeping the coregistration to rigid body transformations allowed the use of several contrasts in the lesion detection task without interfering with the lesions’ morphology and topography. Brain segmentation using CAT showed more stability across the dataset, improving the quality of the subsequent subject registration and consequently of the average brain created. The success of the pipeline led to the possibility of overlaying the manually segmented lesions on the individual and group surfaces where it was found that the majority of lesions occurred on the right hemisphere and that lesion overlaps were more common in cortical sulci. Despite the results obtained, further research is needed to understand the performance of other software packages in the processing of higher resolution MRI data and how to fully exploit these tools in the study of clinical data at 7 T

Neuroimaging of structural pathology and connectomics in traumatic brain injury: Toward personalized outcome prediction.

Recent contributions to the body of knowledge on traumatic brain injury (TBI) favor the view that multimodal neuroimaging using structural and functional magnetic resonance imaging (MRI and fMRI, respectively) as well as diffusion tensor imaging (DTI) has excellent potential to identify novel biomarkers and predictors of TBI outcome. This is particularly the case when such methods are appropriately combined with volumetric/morphometric analysis of brain structures and with the exploration of TBI-related changes in brain network properties at the level of the connectome. In this context, our present review summarizes recent developments on the roles of these two techniques in the search for novel structural neuroimaging biomarkers that have TBI outcome prognostication value. The themes being explored cover notable trends in this area of research, including (1) the role of advanced MRI processing methods in the analysis of structural pathology, (2) the use of brain connectomics and network analysis to identify outcome biomarkers, and (3) the application of multivariate statistics to predict outcome using neuroimaging metrics. The goal of the review is to draw the community's attention to these recent advances on TBI outcome prediction methods and to encourage the development of new methodologies whereby structural neuroimaging can be used to identify biomarkers of TBI outcome